Showing 7221-7230 of 20895 results for "".
- Higher Oxidative Balance Score Tied to Lower Risk of Kidney Stones, Finds Studyhttps://reachmd.com/news/higher-oxidative-balance-score-tied-to-lower-risk-of-kidney-stones-finds-study/2467536/A higher oxidative balance score is tied to a lower risk of kidney stones, according to a study published in the BMC Nephrology.Some studies have found that the pathological formation of kidney stones is closely related to injury and inflammatory response. Behaviors
- Study: Crotoxin Demonstrates Efficacy Against Melanoma with Reduced Toxicityhttps://reachmd.com/news/crotoxin-demonstrates-efficacy-against-melanoma-reduced-toxicity/2467490/A new study in Frontiers in Pharmacology indicated that crotoxin (CTX), a component of snake venom, was associated with antiproliferative effects on melanoma cells. "Melanoma, a highly aggressive skin cancer originating in melanocytes, poses a significant threat due to its metast
- Weekly Cendakimab Dosing Effective in Reducing AD Severityhttps://reachmd.com/news/weekly-cendakimab-dosing-effective-reducing-ad-severity/2467489/New research shows that cendakimab is safe and efficacious at certain dosing levels over a 16-week study period in patients with moderate-to-severe atopic dermatitis (AD). The study authors for the phase 2 trial included 221 adult patients with moderate-to-severe AD from the United States
- How to Control Excessive Sweatinghttps://reachmd.com/news/how-to-control-excessive-sweating/2467485/Board-certified dermatologist shares 6 tips in time for summer ROSEMONT, Ill. (July 17, 2024) — Hyperhidrosis, or excessive sweating, is a common medical condition that affects an estimated 15.8 million people in the U.S. It is no
- HIIT Workouts Proven To Reduce Dementia Risk, According to New Studyhttps://reachmd.com/news/hiit-workouts-proven-to-reduce-dementia-risk-according-to-new-study/2467471/We know that exercise benefits the mind, body, and soul, but new research has revealed that high-intensity interval training (HIIT) can not only improve brain function but also delay the onset of dementia. A study conducted by researchers from the University of Queensland, A
- New Video Test for Parkinson's Uses AI to Track How the Disease Is Progressinghttps://reachmd.com/news/new-video-test-for-parkinsons-uses-ai-to-track-how-the-disease-is-progressing/2467462/A video-processing technique developed at the University of Florida that uses artificial intelligence will help neurologists better track the progression of Parkinson's disease in patients, ultimately enhancing their care and quality of life. The system, developed by Dieg
- Are Plant-Based Meat Alternatives Good for Your Heart?https://reachmd.com/news/are-plant-based-meat-alternatives-good-for-your-heart/2467480/Credit: Unsplash+ Plant-based meat alternatives (PBMAs) are becoming increasingly popular in Canada, aligning with trends in healthier eating and reducing meat consu
- Prioritizing the Psychological Burden of Acne and Rosaceahttps://reachmd.com/news/prioritizing-the-psychological-burden-of-acne-and-rosacea/2467459/Photo Credit: Motortion Given the visibility of facial skin conditions such as acne vulgaris (AV) and rosacea, these diseases are prone to cause internalized stigma.
- TRuE-AD3: Ruxolitinib Cream Safe in Pediatric Atopic Dermatitis Patientshttps://reachmd.com/news/true-ad3-ruxolitinib-cream-safe-in-pediatric-atopic-dermatitis-patients/2467455/Ruxolitinib applied twice daily did not appear to impact hematologic parameters in any clinically meaningful way, according to a new study. "In two randomized phase 3 studies (TRuE-AD1 and TRuE-AD2) evaluating ruxolitinib (Janus kinase [JAK]1/JAK2 inhibitor) cream in
- TRuE-AD3: Ruxolitinib Cream Safe in Pediatric Atopic Dermatitis Patientshttps://reachmd.com/news/true-ad3-ruxolitinib-cream-safe-pediatric-atopic-dermatitis-patients/2467445/Ruxolitinib applied twice daily did not appear to impact hematologic parameters in any clinically meaningful way, according to a new study. "In two randomized phase 3 studies (TRuE-AD1 and TRuE-AD2) evaluating ruxolitinib (Janus kinase [JAK]1/JAK2 inhibitor) cream in adults and adolescent